ACE-011 |
Sotatercept |
ACE-536 |
Luspatercept |
ActRIIA |
Activin receptor type IIA |
ActRIIA-Fc |
Fc domain of human IgG1 |
ActRIIB |
Activin receptor type IIB |
ActRIIB-Fc |
Fc domain of human IgG1 |
ALK1-7 |
Activin-like receptors |
Bcl-x |
B-cell lymphoma-extra large |
BFU-E |
Erythroid burst-forming units |
BMPs |
Bone morphogenetic proteins |
CD34+ |
Cluster of differentiation 34+ |
CFU-E |
Erythroid colony-forming units |
CKD |
Chronic kidney disease |
DAG |
Dyacylglicerol |
DCYTB |
Duodenal Cytochrome B |
DMT1 |
Divalent Metal Transporter 1 |
DOAJ |
Directory of open access journals |
EPC |
EPO-producing cells |
EPO |
Erythropoietin |
EPO-R |
Erythropoietin receptor |
ESAs |
Erythropoiesis-stimulating agents |
FASL |
FAS ligand |
GDF11 |
Growth/differentiating factor 11 |
HI-E |
Hematological erythroid improvement |
HIF |
Hypoxia inducible factor |
HIF-PHD enzymes |
Hypoxia inducible factor prolyl hydrolase domain enzymes |
HSC |
Hematopoietic stem cells |
HSP70 |
Heat shock protein 70 |
IL-3 |
Interleukin 3 |
IP3 |
Inositol-1,4,5-trisphospate |
I-SMAD |
Inhibitory small mother against decapentaplegic |
JAK 2 |
Janus Kinase 2 |
LD |
Linear dichroism |
MAD |
Mothers against decapentaplegic |
MDS |
Myelodysplastic syndromes |
MDS-RS |
Myelodysplastic syndromes with ring sideroblasts |
NTDT |
Non-transfusion-dependent thalassemia |
PI |
Phosphoinositides |
PIP2 |
Phosphatidylinositol (4,5) bisphosphate |
PIP3 |
PtdIns(3,4,5)P3 |
PI3K |
Phosphatidilinositol 3-kinases |
PLCs |
Phospholipases C |
p-SMAD |
Phosphorylated small mother against decapentaplegic |
ROS |
Radical oxygen species |
R-SMAD |
Regulatory small mother against decapentaplegic |
SCF |
Stem cell factor |
SF3B1 |
Splicing factor 3B subunit 1 |
SMAD |
Small mother against decapentaplegic |
STAT5 |
Signal Transducer and Activator of Transcription 5 |
TDT |
Transfusion-dependent thalassemia |
TEA |
Treatment-emergent adverse events |
TGF |
Transforming growth factor |
TNF |
Tumor necrosis factor |
WHO |
World Health Organization |